BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 20, 2005
View Archived Issues
Drug discovery targets for atherosclerosis
Read More
BPC-157 enhances healing during CO2 laser therapy
Read More
ADHD treatment consistency varies with methylphenidate formulations
Read More
Candesartan reduces new-onset diabetes in heart failure patients
Read More
Transdermal 4-hydroxytamoxifen demonstrates activity in breast cancer patients
Read More
Adenoviral interferon beta delivery feasible for pleural malignancies
Read More
Gene therapy with IL-10 ameliorates atherogenesis in mice
Read More
PPARalpha/delta agonists show beneficial effects on HDL-C in primates
Read More
Purdue Pharma suspends Palladone Capsules
Read More
Ortec to begin confirmatory OrCel trial
Read More
Updated labeling for Cialis, Levitra and Viagra
Read More
Brazilian patients receive Zilver PTX paclitaxel-coated stent for PAD
Read More
Xoma to terminate BPI agreement with Zephyr Sciences
Read More
Approvable letter for Pulminiq
Read More
Adherex enters into licensing deal with GlaxoSmithKline
Read More
ChemGenex plans registration-directed trials for Ceflatonin
Read More
Genaissance enters into HAP Technology agreement with Organon
Read More
Nautilus advances improved IFN-beta into preclinical development
Read More
MacroGenics signs agreement for anti-CD3 antibody for type 1 diabetes
Read More
Active Biotech's 57-57 successfully completes first clinical study
Read More
Antitumor efficacy reported for yttrium-90 microspheres
Read More
Sankyo to resume development of CS-917
Read More
Good safety and pharmacokinetic profile of XP-19986 in healthy volunteers
Read More
Rexin-G enters phase I study for pancreatic cancer
Read More
Recent patents describe novel antibacterial agents
Read More
LG Life Sciences claims new agents for acute hepatitis, liver cirrhosis and rheumatoid arthritis
Read More